January 3, 2024

4 Minutes
Medicine

Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis

Voyager Therapeutics have announced a strategic collaboration and capsid license agreement with Novartis Pharma AG, a subsidiary of Novartis AG to advance potential gene therapies for Huntington’s disease (HD) and spinal muscular atrophy (SMA). Voyager will provide...
Read More